Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting GlobeNewswire November 07, 2025 Preclinical data support best-in-class potential of masked T cell engager programs and platform utilizing Xilio's ATACR and SEECR formats, including efficient masking, potent anti-tumor activity and broad therapeutic index Phase 1 data for […]

Nexteer Expands India Technical Center to Advance Driveline Validation Capabilities

Enhances Local Engineering, Validation & Customer Responsiveness Nexteer Automotive, a global leader in intuitive motion control, today announced the expansion of its India Technical Center (INTC) with new driveline physical validation capabilities. https://mma.prnewswire.com/media/2169345/Nexteer_Automotive_Logo.jpg The 1,900-square-meter facility located 20 kilometers from Nexteer's existing INTC in Bengaluru, expands the company's ability to support local OEM customers through

Dragon Shield & Beckett Send First Sleeved TCG Card To the Edge of Space

Rare Beckett Black Label TCG Card to Go to Auction in Support of The Toy Foundation Dragon Shield, aglobal leader in premium trading card game accessories, and Beckett,the premier grading and authentication company for trading cards and collectibles, have made history by sending the first sleeved TCG card to the edge of space, proving the

Diakonos Oncology Presents Promising Preliminary Data from Phase 1 Study of DOC1021 Cell-Based Immunotherapy in Pancreatic Cancer at Society for Immunotherapy of Cancer 40th Annual Meeting

Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, today announced the presentation of Phase 1 data on DOC1021, a patient-specific dendritic cell therapy, in pancreatic ductal adenocarcinoma(PDAC) at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting, being held November 7-9 in National

Maneesh K. Goyal Appointed President and Executive Chairman of Interluxe Group

Interluxe Group, the preeminent luxury-focused experiential agency,today announced that Maneesh K. Goyal has been appointed President, Experiential and Executive Chairman. This announcement follows his appointment to the company's Board of Directors in July 2025. Emma Gwyther will assume the role of Founder and Strategic Advisor, where she will continue to provide strategic guidance and advisory

Anchoring the 15th Five-Year Plan: China’s High-quality Development is Strengthening Foreign Investors’ Confidence

A news report from China.org.cn on the 8th CIIE and China's high-quality development: Recently, China released the “Recommendations of the Central Committee of the Communist Party of China for Formulating the 15th Five-Year Plan for National Economic and Social Development,” which highlights the goal of building a modernized industrial system and a robust domestic market,

Webull Becomes Young Investors Society Sponsor, Furthering Mission to Empower Financial Education Amongst Youth

Financial literacy-focused nonprofit names Webull as official online broker and sponsor of the “Dollar-a-Day Challenge” Webull (NASDAQ: BULL), an online investment platform, today announced its sponsorship of Young Investors Society (YIS), a California-based nonprofit dedicated to empowering financial literacy amongst youth, becoming YIS's official online broker. https://mma.prnewswire.com/media/2278678/Webull_Logo.jpg With financial literacy a key pillar for both

CREATE Medicines Announces Positive First-in-Human Results for MT-302

— Data demonstrates proof-of-mechanism for In Vivo CAR therapy in solid tumors CREATE Medicines Inc. (formerly Myeloid Therapeutics), a biotechnology company advancing in vivo immune-cell programming with mRNA-LNP therapeutics, today announced first-in-human results from its Phase 1 MYE Symphony trial (NCT05969041) evaluating MT-302, an mRNA-LNP-encoded TROP2-targeted in vivo CAR therapy in patients with advanced solid

Westfield Specialty achieves 89.9% CR in Q3 as GWP reaches $1.4bn for the year

WestfieldSpecialty's gross written premium (GWP) climbed to $1.4bn in the first nine months of 2025, with a strong combined ratio of 89.9%, and underwriting income of $92 million pushing the business considerably ahead of plannedresults. This success has been driven by an increased emphasis on diversifying Westfield's Specialty's underwriting lines and appetite, including renewal rights

Wienerschnitzel Honors Veterans and Active-Duty Military with Free Meal on Veterans Day

Present Your U.S. Military ID or Wear Your Uniform to Any Participating Wienerschnitzel on November 11th & Receive a Free Meal Wienerschnitzel,known for selling great American Food, is saluting those who serve this Veterans Day with a special offer of appreciation. https://mma.prnewswire.com/media/2816114/WS_Veterans_Day_2025.jpg OnTuesday, November 11, allveterans and active-duty militaryare invited to enjoy afree Original Chili

Scroll to Top